# EXELON
> **NDA022083** · New Drug Application · Sponsor: SANDOZ · Approved 2007-07-06
## Drug
- **FDA Application Number:** NDA022083
- **Application type:** New Drug Application
- **Brand name:** EXELON
- **Generic name:** RIVASTIGMINE
- **Active ingredients:** RIVASTIGMINE
- **Dosage form:** FILM, EXTENDED RELEASE
- **Route:** TRANSDERMAL
- **Marketing status:** Prescription
- **Sponsor:** SANDOZ
- **Manufacturer:** Sandoz Inc
- **First approval:** 2007-07-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022083)
---
*AI Analytics · CC0 1.0*